Published in Biochemistry on January 26, 1988
Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev (2005) 5.53
Tof1p regulates DNA damage responses during S phase in Saccharomyces cerevisiae. Genetics (2001) 2.03
Molecular basis for expression of common and rare fragile sites. Mol Cell Biol (2003) 1.78
Role of replication protein A as sensor in activation of the S-phase checkpoint in Xenopus egg extracts. Nucleic Acids Res (2011) 0.87
Molecular mechanisms of DNA replication checkpoint activation. Genes (Basel) (2014) 0.80
Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies. Biomolecules (2017) 0.75
Replication Protein A Prohibits Diffusion of the PCNA Sliding Clamp along Single-Stranded DNA. Biochemistry (2017) 0.75
Meningioma and mobile phone use--a collaborative case-control study in five North European countries. Int J Epidemiol (2008) 3.34
Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries. Br J Cancer (2005) 2.54
An abnormal profile of DNA replication intermediates in Bloom's syndrome. Cancer Res (1990) 1.54
Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med (2006) 1.42
Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features. Breast Cancer Res Treat (1994) 1.12
Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis. Breast Cancer Res Treat (1996) 1.09
Demonstration of gene-amplification by PCR in archival paraffin-embedded breast cancer tissue. Breast Cancer Res Treat (1994) 1.08
Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction. Breast Cancer Res Treat (1992) 1.04
Prognostic value of amplification of c-erb-B2 in bladder carcinoma. Clin Cancer Res (1995) 1.01
Prognostic value of erb-B2 and myc amplification in breast cancer imprints. Cancer (1995) 0.97
Determinants of mobile phone output power in a multinational study: implications for exposure assessment. Occup Environ Med (2009) 0.96
Medical history, cigarette smoking and risk of acoustic neuroma: an international case-control study. Int J Cancer (2007) 0.94
Accumulation of 10-kilobase DNA replication intermediates in cells treated with 3-aminobenzamide. Proc Natl Acad Sci U S A (1985) 0.93
Altered formation of DNA replication intermediates in human 46 BR fibroblast cells hypersensitive to 3-aminobenzamide. Carcinogenesis (1989) 0.90
Intratumoral heterogeneity for amplified genes in human breast carcinoma. Int J Cancer (1994) 0.89
DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines. Cancer Res (1986) 0.89
Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma. Cancer Res (1984) 0.84
Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method. Cancer (1993) 0.83
Two discrete DNA replication intermediates are formed in melphalan-treated cells. Biochem Biophys Res Commun (1983) 0.81
C-erb-b2/int-2 amplification appears faster in breast-cancer patients receiving second-line endocrine treatment. Int J Cancer (1996) 0.81
Aphidicolin inhibits the synthesis and joining of short DNA fragments but not the union of 10-kilobase DNA replication intermediates. Proc Natl Acad Sci U S A (1983) 0.81
Reduced repair of X-ray-induced DNA lesions in cells without functioning DNA polymerase alpha. Radiat Res (1985) 0.79
5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole. Cancer Res (1989) 0.79
Appearance and detection of multiple copies of the mdr-1 gene in clinical samples of mammary carcinoma. Int J Cancer (1992) 0.77
Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma. Cancer Res (1988) 0.77
Functional polymorphism in the alcohol dehydrogenase 3 (ADH3) promoter. Pharmacogenetics (2001) 0.77
Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors. Cancer Res (1988) 0.77
Step-wise progression of mammalian 10-kb DNA replication intermediates to mature chromatin. Eur J Biochem (1988) 0.76
Increased levels of 5-fluorouracil-induced DNA lesions in Bloom's syndrome. Int J Cancer (1990) 0.76
There exists a distinct stage during mammalian DNA synthesis immediately after joining of replication intermediates. Nucleic Acids Res (1986) 0.75
Evaluation of prevalent and incident ovarian cancer co-morbidity. Br J Cancer (2012) 0.75
Reduced occurrence of mdr-1 amplification in stage-IV breast-cancer patients treated with tamoxifen compared with other endocrine treatments. Int J Cancer (1993) 0.75
Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in stage-IV breast-cancer patients receiving endocrine treatment. Int J Cancer (1993) 0.75
Melphalan prevents the formation of double-stranded DNA replication intermediates in human malignant melanoma cells. Carcinogenesis (1981) 0.75
Altered formation of DNA replication intermediates in cells growing in different culture conditions. J Cell Physiol (1989) 0.75
Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide). Cancer Res (1989) 0.75
Conversion of post-elongation stage DNA to mature DNA occurs even if movement of the replication fork has stopped. Chromosoma (1987) 0.75
Progressive formation of DNA lesions during treatment with anti-metabolites without incorporation of the drugs into DNA. Mutat Res (1988) 0.75
Appearance of a late stage during mammalian DNA replication when cells resume formation of 10 kb DNA replication intermediates. FEBS Lett (1989) 0.75
Reduced DNA damage induced in human melanoma cells by dacarbazine in the presence of deoxyribonucleosides. Cancer Res (1989) 0.75
Ca2+ and calmodulin are involved in the processes conferring stability to DNA in proliferating neoplastic cells. Int J Cancer (1986) 0.75
The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil. Biochem Pharmacol (1986) 0.75
Double-stranded DNA replication intermediates in human malignant melanoma cells. Cancer Res (1980) 0.75
Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin. Biochem Pharmacol (1988) 0.75
W-7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells. Int J Cancer (1987) 0.75
Reduced formation of high molecular weight DNA in murine gliomas treated with nitrosourea and chlorpromazine. Anticancer Res (1994) 0.75
Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity. Biochem Biophys Res Commun (1987) 0.75
Amplification of oncogenes in mammary carcinoma shown by fine-needle biopsy. Cancer (1991) 0.75
5,6-Dichloro-1-beta-O-ribofuranosylbenzimidazole induces DNA damage by interfering with DNA topoisomerase II. Eur J Biochem (1987) 0.75
Ascorbate-Cu2+ fragments melanoma DNA but not fibroblast DNA into a discrete DNA population. Carcinogenesis (1983) 0.75
Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues. Mol Pharmacol (1987) 0.75
Leucovorine prevents methotrexate from inducing DNA lesions. Biochem Biophys Res Commun (1986) 0.75
Bleomycin-induced DNA lesions are dependent on nucleosome repeat length. Biochem Pharmacol (1990) 0.75
Higher frequency of gene amplification in breast cancer patients who received adjuvant chemotherapy. Cancer (1996) 0.75